Rapid approval of generic drugs eyed

Published: 2011-01-21 07:00:00

Updated: 2011-01-21 07:00:00

The Korea Food and Drug Administration recently unveiled its plan to provide better support for the domestic drug makers to develop generic product over new brands that are subject to re-examination.

The KFDA said that if a person intends to develop a drug which is identical with an item subje...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK